| Market Cap | ₹1,32,898Cr |
| ROE | 16.90% |
| P/E Ratio(TTM) | 24.68 |
| EPS(TTM) | 66.67 |
| P/B Ratio | 4.26 |
| Dividend Yield | 0.97% |
| Industry P/E | 35.31 |
| Book Value | 386.17 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
| Parent Organisation | Cipla Limited |
| Managing Director | Mr. Umang Vohra |
| NSE Symbol | CIPLA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 38.98 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.60 | ||
| Zydus Lifesciences | NA (0.00%) | 21.52 | ||
| Mankind Pharma | NA (0.00%) | 52.85 |